Introduction. Acute myocardial infarction has negative influence on patient?s
quality of life. The objective of the paper was to assess the healthrelated
quality of life in the patients one month and twelve months after acute
myocardial infarction and to compare it with the healthy controls. Material
and Methods. A prospective cohort study involved 160 patients aged from 30 to
79 and 240 healthy controls. The health-related quality of life was assessed
with the Serbian version of these questionnaires: Euro- Quol-5-Dimension and
EuroQuolVAS. Angina pectoris was ranked according to the classification of
Canadian Cardiovascular Society. Multivariate logistic regression analysis
was used. Results. The healthy controls had significantly higher average
scores in EuroQuolVAS compared with the patients one month after acute
myocardial infarction (74.35?9.42 vs 60.50?12.03, p<0.001), as well as twelve
months after acute myocardial infarction (74.35?9.42 vs 69.83?12.06,
p<0.001). Significantly lower average ranges in EuroQuol-5-Dimension
questionnaire and higher quality of life were found twelve months after acute
myocardial infarction than one month after acute myocardial infarction
(1.41?0.26 vs 1.53?0.26, p<0.001). The average ranges of angina pectoris were
significantly lower in all the patients twelve months after acute myocardial
infarction compared with the first month (0.78?0.51 vs 0.91?0.44, p<0.001).
The multivariate regression analysis confirmed thrombolytic therapy,
percutaneous transluminal angioplasty and age to be important factors
influencing health-related quality of life. Conclusion. The patients assessed
their health condition to be significantly higher twelve months after acute
myocardial infarction than one month after it. The health-related quality of
life was significantly higher in patients who had undergone the percutaneous
intervention than in those who had been treated with the thrombolytic
therapy.
Health-related quality of life in fibromyalgia and refractory angina pectoris: A comparison between two chronic non-malignant pain disorders
